By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Protagen and the Natural and Medical Sciences Institute at the University of Tubingen announced they will be developing multiplex assays for the diagnosis of autoimmune diseases and cancer.

The deal will leverage Protagen's expertise in the high-throughput expression of human proteins and clinical validation studies, and the institute's research platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.